Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003567914 | SCV004309944 | likely benign | not provided | 2024-09-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004756523 | SCV005341914 | uncertain significance | SLC44A4-related disorder | 2024-09-06 | no assertion criteria provided | clinical testing | The SLC44A4 c.1038-6C>G variant is predicted to interfere with splicing. This variant is predicted to alter splicing based on available splicing prediction software (SpliceAI, Jaganathan et al. 2019. PubMed ID: 30661751). However, the use of computer prediction softwares is not equivalent to functional evidence. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.035% of alleles in individuals of Latino descent in gnomAD, which may be too high for causative variant. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |